J. Kevin Buchi Net Worth & Insider Trades

J. Kevin Buchi - President & CEO, Tetralogic Pharmaceuticals Corp

As of March 30, 2015

What is J. Kevin Buchi's Net Worth?

The current estimated net worth of Tetralogic Pharmaceuticals Corp's President & CEO, J. Kevin Buchi, is estimated to be about $80.75K . J. Kevin Buchi owns about 330,714 units of Tetralogic Pharmaceuticals Corp common stock. In the last 3 months at Tetralogic Pharmaceuticals Corp, J. Kevin Buchi has sold an estimated value of $0 worth.

What is J. Kevin Buchi's Past Insider Trading?

J. Kevin Buchi's largest purchase order was 5,000 units , worth over $25.18K on January 9, 2015. In total, J. Kevin Buchi has made about 3 transactions over 3 months of their time at Tetralogic Pharmaceuticals Corp. J. Kevin Buchi usually trades in January, with the busiest year in 2015. The most recent transaction was a purchase order of 5,000 units , worth over $21.15K on March 30, 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is J. Kevin Buchi's' Mailing Address?

  • Mailing address is 41 Moores Road Frazer PA 19355 PA

What are Tetralogic Pharmaceuticals Corp's Past Insider Trades?

Tetralogic Pharmaceuticals Corp's most recent insider trade came on February 10, 2016 by Clarus Lifesciences Ii Lp, Clarus Ventures Ii GP Lp, Clarus Ventures Ii Llc, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, Michael Steinmetz and Kurt Wheeler who sold 333,630 units worth $56.47K . In the last 3 years, insiders at Tetralogic Pharmaceuticals Corp have sold an estimated value of $463.13K and bought an estimated value of $2.26M worth of shares. Insider trading is most common in January, with the busiest year in 2015. The most active traders at the company are Michael Steinmetz,  Clarus Lifesciences Ii Lp,  and Clarus Ventures Ii GP Lp .

TETRALOGIC PHARMACEUTICALS Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1